0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
JAMA Patient Page |

Neonatal Hyperbilirubinemia FREE

Ann R. Punnoose, MD; Laura A. Schwartz, MS; Robert M. Golub, MD
JAMA. 2012;307(19):2115. doi:10.1001/jama.2012.4070.
Text Size: A A A
Published online

Bilirubin is one of the products that is formed when red blood cells are broken down. Bilirubin is taken up by the liver and changed by an enzyme (protein that speeds up chemical reactions in the body) in the liver. It is then excreted through urine or stool. In newborn infants, this enzyme may work slowly or may not be present in large enough quantities to help remove bilirubin efficiently. This often causes jaundice, a yellowing of the skin and whites of the eyes, and is usually considered a physiologic (normal) jaundice that does not need to be treated. If infants have certain risk factors or become dehydrated because they are not drinking enough breast milk or formula, they might not be able to excrete bilirubin. This can lead to abnormally increased levels of the unchanged bilirubin in newborn infants' blood, a condition called neonatal hyperbilirubinemia.

RISK FACTORS

These may prompt physicians to check bilirubin levels soon after birth:

  • ABO incompatibility. This happens when a mother's blood type is group O and her infant's is either group A or B. Maternal antibodies (proteins that are part of the body's immune response) to group A or B blood are transported to the fetus and can cause a breakdown of red blood cells (hemolysis) in the infant, leading to hyperbilirubinemia.

  • Heavy bruising from delivery. Bruises can result in old blood collecting under the skin, which can result in increased production of bilirubin.

  • Family history of any disorders that lead to increased hemolysis, like glucose-6-phosphate dehydrogenase deficiency.

  • Infants born before the 35th week of pregnancy.

  • A sibling who required treatment for hyperbilirubinemia at birth.

  • East Asian race, as identified by the infant's parents.

  • Jaundice noted within the first 24 hours of life.

  • Excessive weight loss, which might signal that the infant is not getting enough breast milk or formula.

SCREENING

The American Academy of Pediatrics recommends that newborn infants be looked at frequently while they are in the newborn nursery to see if they are jaundiced. Additionally, many hospitals check infants' bilirubin levels before they are discharged home regardless of risk factors and their appearance on examination. Hospital physicians may also recommend that infants' bilirubin levels be checked again by their pediatrician at the first newborn visit, a few days after discharge from the hospital.

TREATMENT

Whether a particular bilirubin level is considered high depends on the infant's age (in hours) when the blood was drawn as well as whether the infant is full term or premature or has any of the risk factors.

  • Phototherapy (treatment by exposure to light). Infants are placed in incubators, under a special light source (blue-green spectrum) with their eyes covered. The lights change the structure of bilirubin so that it is easily excreted in urine or stool. The intensity of phototherapy can be varied depending on the bilirubin level.

  • Exchange transfusion, removing the infant's blood and replacing it with blood matched for blood group that is free of bilirubin. This treatment is used when bilirubin levels are extremely high or are increasing too quickly to be treated by phototherapy. Extremely high levels of bilirubin can injure the brain (kernicterus) and lead to severe neurological impairment.

FOR MORE INFORMATION

INFORM YOURSELF

To find this and previous JAMA Patient Pages, go to the Patient Page link on JAMA 's website at www.jama.com. Many are available in English and Spanish.

Sources: American Academy of Pediatrics, Centers for Disease Control and Prevention, Mayo Clinic

This article was corrected for errors on July 20, 2012.

The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call 312/464-0776.

TOPIC: Neonatology

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Spanish Patient Page: Hiperbilirrubinemia neonatal

Supplemental Content

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Related Collections
PubMed Articles